{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:33Z","timestamp":1769126433975,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["824B2063"],"award-info":[{"award-number":["824B2063"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Chinese Foundation for Hepatitis Prevention and Control","award":["GRG202301"],"award-info":[{"award-number":["GRG202301"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-04100-6","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:05:38Z","timestamp":1768925138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum N-glycan NA3Fb identified as a prognostic biomarker of poor outcome in HBV-related hepatocellular carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Pengyuan","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"issue":"3","key":"4100_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal For Clinicians. 2021;71(3):209\u201349.","journal-title":"CA: a Cancer Journal For Clinicians"},{"issue":"1","key":"4100_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41572-021-00245-6","volume":"7","author":"Hepatocellular carcinoma","year":"2021","unstructured":"Hepatocellular carcinoma. Nat Reviews Disease Primers. 2021;7(1):7.","journal-title":"Nat Reviews Disease Primers"},{"issue":"2","key":"4100_CR3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3350\/cmh.2022.0402","volume":"29","author":"D Xie","year":"2023","unstructured":"Xie D, Shi J, Zhou J, et al. Clinical practice guidelines and real-life practice in hepatocellular carcinoma: a Chinese perspective. Clin Mol Hepatol. 2023;29(2):206\u201316.","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"4100_CR4","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/JS9.0000000000000806","volume":"110","author":"X He","year":"2024","unstructured":"He X, Xu S, Tang L, et al. Insights into the history and tendency of liver transplantation for liver cancer: a bibliometric-based visual analysis. International Journal of Surgery (London, England). 2024;110(1):406\u201318.","journal-title":"International Journal of Surgery (London, England)"},{"issue":"8","key":"4100_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","volume":"18","author":"B Sangro","year":"2021","unstructured":"Sangro B, Sarobe P, Herv\u00e1s-Stubbs S, et al. Advances in immunotherapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2021;18(8):525\u201343.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"4100_CR6","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s12072-025-10799-2","volume":"19","author":"W Zhu","year":"2025","unstructured":"Zhu W, Fan C, Zhao Y, et al. Breaking bottlenecks: the future of hepatocellular carcinoma clinical trials and therapeutic targets. Hepatol Int. 2025;19(4):888\u2013902.","journal-title":"Hepatol Int"},{"issue":"9","key":"4100_CR7","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015;15(9):540\u201355.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"4100_CR8","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrm3383","volume":"13","author":"KW Moremen","year":"2012","unstructured":"Moremen KW, Tiemeyer M, Nairn AV. Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol. 2012;13(7):448\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4100_CR9","doi-asserted-by":"publisher","first-page":"893365","DOI":"10.3389\/fimmu.2022.893365","volume":"13","author":"B Radovani","year":"2022","unstructured":"Radovani B, Gudelj I. N-glycosylation and inflammation; the not-so-sweet relation. Front Immunol. 2022;13:893365.","journal-title":"Front Immunol"},{"issue":"10","key":"4100_CR10","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1177\/0300060518789304","volume":"46","author":"M Wu","year":"2018","unstructured":"Wu M, Liu H, Liu Z, et al. Analysis of serum alpha-fetoprotein (AFP) and AFP-L3 levels by protein microarray. J Int Med Res. 2018;46(10):4297\u2013305.","journal-title":"J Int Med Res"},{"issue":"34","key":"4100_CR11","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.3748\/wjg.v26.i34.5130","volume":"26","author":"NK Gatselis","year":"2020","unstructured":"Gatselis NK, Tornai T, Shums Z, et al. Golgi protein-73: a biomarker for assessing cirrhosis and prognosis of liver disease patients. World J Gastroenterol. 2020;26(34):5130\u201345.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"4100_CR12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm1006","volume":"10","author":"N Callewaert","year":"2004","unstructured":"Callewaert N, Van Vlierberghe H, Van Hecke A, et al. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med. 2004;10(4):429\u201334.","journal-title":"Nat Med"},{"issue":"5","key":"4100_CR13","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/hep.21855","volume":"46","author":"X-E Liu","year":"2007","unstructured":"Liu X-E, Desmyter L, Gao C-F, et al. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. Hepatology. 2007;46(5):1426\u201335.","journal-title":"Hepatology"},{"key":"4100_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.eng.2023.03.008","volume":"26","author":"L Wang","year":"2023","unstructured":"Wang L, Liu Y, Gu Q, et al. Serum N-glycan markers for diagnosing significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal alanine aminotransferase levels. Engineering. 2023;26:151\u20138.","journal-title":"Engineering"},{"issue":"11","key":"4100_CR15","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1158\/1078-0432.CCR-16-1500","volume":"23","author":"X Verhelst","year":"2017","unstructured":"Verhelst X, Vanderschaeghe D, Cast\u00e9ra L, et al. A Glycomics-Based test predicts the development of hepatocellular carcinoma in cirrhosis. Clin Cancer Research: Official J Am Association Cancer Res. 2017;23(11):2750\u20138.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"key":"4100_CR16","doi-asserted-by":"crossref","unstructured":"Su R, Tao X, Yan L, et al. Early screening, diagnosis and recurrence monitoring of hepatocellular carcinoma in chronic hepatitis B patients based on serum N-glycomics analysis: A cohort study. Hepatology (Baltimore, Md.); 2025.","DOI":"10.1097\/HEP.0000000000001316"},{"issue":"5","key":"4100_CR17","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1007\/s12072-024-10709-y","volume":"18","author":"C Zhang","year":"2024","unstructured":"Zhang C, Liu Y, Wang L, et al. Dose-response relationship between serum N-glycan markers and liver fibrosis in chronic hepatitis B. Hepatol Int. 2024;18(5):1434\u201347.","journal-title":"Hepatol Int"},{"key":"4100_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.10.003","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, He Y, Luo N, et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell. 2019. https:\/\/doi.org\/10.1016\/j.cell.2019.10.003.","journal-title":"Cell"},{"issue":"1","key":"4100_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jhep.2024.07.018","volume":"82","author":"H-C Mon","year":"2025","unstructured":"Mon H-C, Lee P-C, Hung Y-P, et al. Functional cure of hepatitis B in patients with cancer undergoing immune checkpoint inhibitor therapy. J Hepatol. 2025;82(1):51\u201361.","journal-title":"J Hepatol"},{"issue":"1","key":"4100_CR20","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"EASL Clinical Practice Guidelines","year":"2018","unstructured":"EASL Clinical Practice Guidelines. Management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182\u2013236.","journal-title":"J Hepatol"},{"issue":"9","key":"4100_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102400","volume":"298","author":"N Osada","year":"2022","unstructured":"Osada N, Nagae M, Nakano M, et al. Examination of differential glycoprotein preferences of N-acetylglucosaminyltransferase-IV isozymes a and b. J Biol Chem. 2022;298(9):102400.","journal-title":"J Biol Chem"},{"issue":"10","key":"4100_CR22","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/s41590-023-01614-x","volume":"24","author":"L Till\u00e9","year":"2023","unstructured":"Till\u00e9 L, Cropp D, Charmoy M, et al. Activation of the transcription factor NFAT5 in the tumor microenvironment enforces CD8\u2009+\u2009T cell exhaustion. Nat Immunol. 2023;24(10):1645\u201353.","journal-title":"Nat Immunol"},{"issue":"1","key":"4100_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canlet.2015.02.005","volume":"360","author":"K Pham","year":"2015","unstructured":"Pham K, Luo D, Siemann DW, et al. VEGFR inhibitors upregulate CXCR4 in VEGF receptor-expressing glioblastoma in a TGF\u03b2R signaling-dependent manner. Cancer Lett. 2015;360(1):60\u20137.","journal-title":"Cancer Lett"},{"issue":"7","key":"4100_CR24","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/j.1349-7006.2008.00839.x","volume":"99","author":"Y-Y Zhao","year":"2008","unstructured":"Zhao Y-Y, Takahashi M, Gu J-G, et al. Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Sci. 2008;99(7):1304\u201310.","journal-title":"Cancer Sci"},{"issue":"1","key":"4100_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41467-019-14050-z","volume":"11","author":"B Losic","year":"2020","unstructured":"Losic B, Craig AJ, Villacorta-Martin C, et al. Intratumoral heterogeneity and clonal evolution in liver cancer. Nat Commun. 2020;11(1):291.","journal-title":"Nat Commun"},{"issue":"1","key":"4100_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/apt.17748","volume":"59","author":"E Butaye","year":"2024","unstructured":"Butaye E, Somers N, Grossar L, et al. Systematic review: glycomics as diagnostic markers for hepatocellular carcinoma. Aliment Pharmacol Ther. 2024;59(1):23\u201338.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"4100_CR27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S1665-2681(19)31025-7","volume":"11","author":"Y Qu","year":"2012","unstructured":"Qu Y, Gao C-F, Zhou K, et al. Serum N-glycomic markers in combination with panels improves the diagnosis of chronic hepatitis B. Ann Hepatol. 2012;11(2):202\u201312.","journal-title":"Ann Hepatol"},{"issue":"12","key":"4100_CR28","doi-asserted-by":"publisher","first-page":"e1011503","DOI":"10.1080\/2162402X.2015.1011503","volume":"4","author":"C-H Yi","year":"2015","unstructured":"Yi C-H, Weng H-L, Zhou F-G, et al. Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinoma. Oncoimmunology. 2015;4(12):e1011503.","journal-title":"Oncoimmunology"},{"key":"4100_CR29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140453","author":"G Haddad","year":"2021","unstructured":"Haddad G, Lorenzen JM, Ma H, et al. Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI140453.","journal-title":"J Clin Invest"},{"issue":"1","key":"4100_CR30","doi-asserted-by":"publisher","first-page":"344","DOI":"10.21037\/jgo-22-93","volume":"13","author":"L Guo","year":"2022","unstructured":"Guo L, Wan L, Hu Y, et al. Serum N-glycan profiling as a diagnostic biomarker for the identification of hepatitis B virus-associated hepatocellular carcinoma. J Gastrointest Oncol. 2022;13(1):344\u201354.","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"4100_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/ijc.25030","volume":"127","author":"M Fang","year":"2010","unstructured":"Fang M, Zhao Y-P, Zhou F-G, et al. N-glycan based models improve diagnostic efficacies in hepatitis B virus-related hepatocellular carcinoma. Int J Cancer. 2010;127(1):148\u201359.","journal-title":"Int J Cancer"},{"issue":"10","key":"4100_CR32","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3748\/wjg.v26.i10.1067","volume":"26","author":"X Cao","year":"2020","unstructured":"Cao X, Shang Q-H, Chi X-L, et al. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus. World J Gastroenterol. 2020;26(10):1067\u201379.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"4100_CR33","doi-asserted-by":"publisher","first-page":"14473","DOI":"10.1096\/fj.202001168RR","volume":"34","author":"X Wang","year":"2020","unstructured":"Wang X, Lin Y, Liu S, et al. O-GlcNAcylation modulates HBV replication through regulating cellular autophagy at multiple levels. FASEB J. 2020;34(11):14473\u201389.","journal-title":"FASEB J"},{"issue":"3","key":"4100_CR34","doi-asserted-by":"publisher","first-page":"e0299403","DOI":"10.1371\/journal.pone.0299403","volume":"19","author":"P Tepjanta","year":"2024","unstructured":"Tepjanta P, Fujiyama K, Misaki R, et al. The N-linked glycosylation modifications in the hepatitis B surface protein impact cellular autophagy, HBV replication, and HBV secretion. PLoS One. 2024;19(3):e0299403.","journal-title":"PLoS One"},{"issue":"5\u20136","key":"4100_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10719-012-9414-1","volume":"29","author":"J Fan","year":"2012","unstructured":"Fan J, Wang S, Yu S, et al. N-acetylglucosaminyltransferase IVa regulates metastatic potential of mouse hepatocarcinoma cells through glycosylation of CD147. Glycoconj J. 2012;29(5\u20136):323\u201334.","journal-title":"Glycoconj J"},{"key":"4100_CR36","doi-asserted-by":"publisher","first-page":"16007","DOI":"10.1038\/srep16007","volume":"5","author":"H Nie","year":"2015","unstructured":"Nie H, Liu X, Zhang Y, et al. Specific N-glycans of hepatocellular carcinoma cell surface and the abnormal increase of core-\u03b1-1, 6-fucosylated triantennary glycan via N-acetylglucosaminyltransferases-IVa regulation. Sci Rep. 2015;5:16007.","journal-title":"Sci Rep"},{"issue":"48","key":"4100_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409764","volume":"11","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Sun J, Xu W, et al. MGAT4A\/Galectin9-Driven N-Glycosylation Aberration as a Promoting Mechanism for Poor Prognosis of Endometrial Cancer with TP53 Mutation. Adv Sci. 2024;11(48):e2409764.","journal-title":"Adv Sci"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-04100-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04100-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04100-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T07:44:27Z","timestamp":1769067867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-025-04100-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4100"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-04100-6","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}